Artificial Intelligence Applications in Type 2 Diabetes Mellitus Care: Focus on Machine Learning Methods

被引:52
作者
Abhari, Shahabeddin [1 ]
Kalhori, Sharareh R. Niakan [1 ]
Ebrahimi, Mehdi [2 ,3 ]
Hasannejadasl, Hajar [1 ]
Garavand, Ali [4 ]
机构
[1] Univ Tehran Med Sci, Sch Allied Med Sci, Dept Hlth Informat Management, Tehran, Iran
[2] Univ Tehran Med Sci, Sch Med, Dept Internal Med, Tehran, Iran
[3] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Res Inst, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Hlth Informat Management & Technol, Tehran, Iran
关键词
Artificial Intelligence; Diabetes Mellitus; Machine Learning; Diabetes Care; Health Informatics; CANCER PREDICTION; NEURAL-NETWORK; PREVALENCE; INFORMATION; ALGORITHMS; MANAGEMENT; DIAGNOSIS; KNOWLEDGE; GLUCOSE; SYSTEM;
D O I
10.4258/hir.2019.25.4.248
中图分类号
R-058 [];
学科分类号
摘要
Objectives: The incidence of type 2 diabetes mellitus has increased significantly in recent years. With the development of artificial intelligence applications in healthcare, they are used for diagnosis, therapeutic decision making, and outcome prediction, especially in type 2 diabetes mellitus. This study aimed to identify the artificial intelligence (AI) applications for type 2 diabetes mellitus care. Methods: This is a review conducted in 2018. We searched the PubMed, Web of Science, and Embase scientific databases, based on a combination of related mesh terms. The article selection process was based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Finally, 31 articles were selected after inclusion and exclusion criteria were applied. Data gathering was done by using a data extraction form. Data were summarized and reported based on the study objectives. Results: The main applications of AI for type 2 diabetes mellitus care were screening and diagnosis in different stages. Among all of the reviewed AI methods, machine learning methods with 71% (n = 22) were the most commonly applied techniques. Many applications were in multi method forms (23%). Among the machine learning algorithms applications, support vector machine (21%) and naive Bayesian (19%) were the most commonly used methods. The most important variables that were used in the selected studies were body mass index, fasting blood sugar, blood pressure, HbA1c, triglycerides, low-density lipoprotein, high-density lipoprotein, and demographic variables. Conclusions: It is recommended to select optimal algorithms by testing various techniques. Support vector machine and naive Bayesian might achieve better performance than other applications due to the type of variables and targets in diabetes-related outcomes classification.
引用
收藏
页码:248 / 261
页数:14
相关论文
共 75 条
[21]   Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania - a prospective study [J].
Dargis, V ;
Pantelejeva, O ;
Jonushaite, A ;
Vileikyte, L ;
Boulton, AJM .
DIABETES CARE, 1999, 22 (09) :1428-1431
[22]   Classification and Prediction of Brain Disorders Using Functional Connectivity: Promising but Challenging [J].
Du, Yuhui ;
Fu, Zening ;
Calhoun, Vince D. .
FRONTIERS IN NEUROSCIENCE, 2018, 12
[23]  
Ettore Eric, 2016, Soins Gerontol, V21, P15, DOI 10.1016/j.sger.2016.07.004
[24]  
Fallah M, 2017, HEALTHC INFORM RES, V23, P262, DOI 10.4258/hir.2017.23.4.262
[25]   Predictive models to assess risk of type 2 diabetes, hypertension and comorbidity: machine-learning algorithms and validation using national health data from Kuwait-a cohort study [J].
Farran, Bassam ;
Channanath, Arshad Mohamed ;
Behbehani, Kazem ;
Thanaraj, Thangavel Alphonse .
BMJ OPEN, 2013, 3 (05)
[26]   Artificial intelligence in medicine [J].
Hamet, Pavel ;
Tremblay, Johanne .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 69 :S36-S40
[27]  
Han J, 2012, MOR KAUF D, P1
[28]   An interpretable rule-based diagnostic classification of diabetic nephropathy among type 2 diabetes patients [J].
Huang, Guan-Mau ;
Huang, Kai-Yao ;
Lee, Tzong-Yi ;
Weng, Julia Tzu-Ya .
BMC BIOINFORMATICS, 2015, 16
[29]  
International Diabetes Association, 2012, NEW EST 2012 DIAB PR
[30]  
Javad OM, 2015, P ASME 2015 INT MECH